Sensitivity and specificity of plasma disappearance rate of indocyanine green as a prognostic indicator in acute liver failure

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Merle, Uta ^a   Sieg, Olivia ^a   Stremmel, Wolfgang ^a   Encke, Jens ^b   Eisenbach, Christoph ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b JOHANNA ETIENNE KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; COLORING AGENT; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DENSITOMETRY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LIVER CELL DAMAGE; LIVER FAILURE; LIVER ISCHEMIA; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VIRUS HEPATITIS; ADOLESCENT; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLORING AGENTS; DENSITOMETRY; DISEASE PROGRESSION; FEMALE; HUMANS; INDOCYANINE GREEN; INJECTIONS, INTRAVENOUS; LIVER FAILURE, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 72549092830     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-91     Document Type: Article

References (21)

1. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137(12):947-954.
2. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41(5):1179-1197. 10.1002/hep.20703, 15841455.
3. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97(2):439-445.
4. Wu CC, Ho WL, Yeh DC, Huang CR, Liu TJ, P'Eng FK. Hepatic resection of hepatocellular carcinoma in cirrhotic livers: is it unjustified in impaired liver function?. Surgery 1996, 120(1):34-39. 10.1016/S0039-6060(96)80238-8, 8693420.
5. Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, Tanaka T, Tomoda F. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 1994, 219(4):342-346. 10.1097/00000658-199404000-00003, 1243149, 8161258.
6. Midorikawa Y, Kubota K, Takayama T, Toyoda H, Ijichi M, Torzilli G, Mori M, Makuuchi M. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 1999, 126(3):484-491.
7. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992, 163(5):515-518. 10.1016/0002-9610(92)90400-L, 1575310.
8. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984, 95(5):586-592.
9. Plevris JN, Jalan R, Bzeizi KI, Dollinger MM, Lee A, Garden OJ, Hayes PC. Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol 1999, 30(1):142-148. 10.1016/S0168-8278(99)80018-X, 9927161.
10. Tsubono T, Todo S, Jabbour N, Mizoe A, Warty V, Demetris AJ, Starzl TE. Indocyanine green elimination test in orthotopic liver recipients. Hepatology 1996, 24(5):1165-1171. 10.1002/hep.510240531, 8903393.
11. Sakka SG, Reinhart K, Meier-Hellmann A. Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 2002, 122(5):1715-1720. 10.1378/chest.122.5.1715, 12426276.
12. Leevy CM, Smith F, Longueville J, Paumgartner G, Howard MM. Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry. Jama 1967, 200(3):236-240. 10.1001/jama.200.3.236, 6071462.
13. Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of invasive and noninvasive measurements of indocyanine green plasma disappearance rate in critically ill patients with mechanical ventilation and stable hemodynamics. Intensive Care Med 2000, 26(10):1553-1556. 10.1007/s001340000639, 11126271.
14. Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, Hetz H. Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study. Liver Transpl 2004, 10(8):1060-1064. 10.1002/lt.20205, 15390334.
15. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124(1):91-96. 10.1053/gast.2003.50016, 12512033.
16. Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003, 31(1):299-305. 10.1097/00003246-200301000-00048, 12545033.
17. Inderbitzin D, Muggli B, Ringger A, Beldi G, Gass M, Gloor B, Uehlinger D, Regli B, Reichen J, Candinas D. Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients. J Gastrointest Surg 2005, 9(8):1155-1161. discussion 1161-1152, 10.1016/j.gassur.2005.07.026, 16269387.
18. Bruegger L, Studer P, Schmid SW, Pestel G, Reichen J, Seiler C, Candinas D, Inderbitzin D. Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation. J Gastrointest Surg 2008, 12(1):67-72. 10.1007/s11605-007-0352-3, 17960466.
19. Paumgartner G. The handling of indocyanine green by the liver. Schweiz Med Wochenschr 1975, 105(17 Suppl):1-30.
20. Cherrick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 1960, 39:592-600. 10.1172/JCI104072, 293343, 13809697.
21. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961, 21:43-57.